Frontiers in Immunology · 2017 · 100 citations · 44 references
Life SciencesImmunologyMolecular BiologyEpigeneticsGene ExpressionTranscriptional RegulationChromatinCytokine BiologyFibrosisInterstitial Lung DiseaseMacrophage BiologyPulmonary InflammationChromatin AccessibilityEpigenetic RegulationEpigenetic Regulation Of FibrosisHistone AcetylationHistone Acetyltransferase InhibitionInflammation-related Epigenetic ChangeMacrophage Transcriptional RegulationPulmonary Fibrosis Progression
Overexpression of IL-6 has been proposed to contribute to pulmonary fibrosis and other fibrotic diseases. However, the regulatory mechanisms as well as the role of IL-6 in fibrosis remain poorly understood. Epigenetics refers to alterations of gene expression without changes in the DNA sequence. Alternation of chromatin accessibility by histone acetylation acts as a critical epigenetic mechanism to regulate a variety of gene transcription. The goal of this study was to determine the impact of IL-6 in paraquat induced pulmonary fibrosis and to explore whether the epigenetic regulations may play a role in transcriptional regulation of IL-6. In paraquat treated lungs and macrophages, we found that the mRNA and protein expression of IL-6 was robustly increased in a time-dependent and a dose-dependent manner. Our data demonstrated that paraquat induced IL-6 expression in macrophages plays a central role in pulmonary fibrosis through enhanced epithelial to mesenchymal transition (EMT). IL-6 expression and its role to enhance paraquat induced pulmonary fibrosis were increased by HDAC inhibition and prevented by HAT inhibition. In addition, the ability of CRISPR-ON transcription activation system (CRISPR-ON) to promote transcription of IL-6 was enhanced by HAT inhibitor and blocked by HDAC inhibitor. We further showed that ChIP experiments revealed that HDAC inhibitors increase histones activation marks H3K4me3 and H3K9ac at IL-6 promoter regions. In conclusion, IL-6 functioning through EMT in paraquat induced pulmonary fibrosis was regulated dynamically by HDAC and HAT both in vitro and in vivo via epigenetically regulating chromatin accessibility.
44
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann, Mark D. Brigham, Alexandro E. Trevino et al. · Nature · 2014 · 2.9K citations
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.
Xuebing Wu, David Scott, Andrea J. Kriz et al. · PubMed · 2014 · 989 citations
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Kazuhiro Ito, Misako Ito, W. Mark Elliott et al. · New England Journal of Medicine · 2005 · 962 citations · Full text